Recent Finacing
Recent Raise
ProfoundBio is a clinical-stage biotech developing antibody–drug conjugates using proprietary platforms, advancing multiple ADC candidates for solid tumors and hematologic malignancies targeting FRα, CD70, PTK7 and bispecific ADCs.
